🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for revolutionary discoveries that illuminate how the immune system targets harmful infections while protecting the body's own cells.

A trio of renowned scientists—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

The research uncovered unique "security guards" within the defense system that eliminate rogue defense cells capable of harming the body.

These discoveries are now paving the way for innovative therapies for immune disorders and cancer.

The laureates will divide a prize fund valued at 11m Swedish kronor.

Crucial Discoveries

"The research has been essential for understanding how the body's defenses functions and why we do not all suffer from severe autoimmune diseases," stated the head of the award panel.

This team's studies address a fundamental question: How does the defense system defend us from countless invaders while leaving our healthy cells intact?

Our body's protection system employs white blood cells that search for indicators of disease, even pathogens and bacteria it has never encountered.

These defenders employ detectors—called receptors—that are generated by chance in a vast number of variations.

That gives the immune system the ability to fight a broad range of threats, but the randomness of the mechanism inevitably produces immune cells that may target the host.

Protectors of the Immune System

Researchers previously understood that some of these harmful white blood cells were destroyed in the thymus—the site where immune cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—described as the immune system's "security guards"—which travel through the system to neutralize any defenders that attack the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee stated, "The findings have established a new field of investigation and spurred the development of new treatments, for instance for cancer and autoimmune diseases."

In malignancies, regulatory T-cells block the body from fighting the tumor, so research are focused on lowering their numbers.

For autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is not being harmed. A similar approach could also be effective in minimizing the risks of transplanted organ rejection.

Innovative Studies

Prof Sakaguchi, of Osaka University, performed tests on rodents that had their immune gland removed, causing self-attack conditions.

He demonstrated that injecting defense cells from healthy mice could prevent the illness—suggesting there was a mechanism for blocking defenders from attacking the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an genetic immune disorder in rodents and humans that led to the identification of a genetic factor vital for how regulatory T-cells operate.

"Their pioneering research has uncovered how the immune system is kept in check by T-reg cells, stopping it from accidentally targeting the healthy cells," said a leading biological science expert.

"This work is a remarkable example of how basic biological research can have broad implications for human health."